Clinical Trial Update: Ph2 Gem/Nov/Rituxan Rel/Ref MantleCell [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of gemcitabine, mitoxantrone (Novantrone), and rituximab for relapsed or refractory mantle cell lymphoma has completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Gemzar (gemcitabine) (gemcitabine)
• Novantrone (mitoxantrone) (mitoxantrone)
• Rituxan (rituximab) (rituximab)

Snippet

Sponsor: US Oncology Research | Conditions: Relapsed or Refractory Mantle Cell Lymphoma (MCL) | Phase 2 | Status: COMPLETED | Results posted: 2016-11-03